The Goldman Sachs Group, Inc. (GS) 13D/13G Filings for ProQR Therapeutics N.V. (PRQR)

The Goldman Sachs Group, Inc. 13D and 13G filings for ProQR Therapeutics N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-07
6:11 pm
Sale		 2022-12-30 13G ProQR Therapeutics N.V.
PRQR		 GOLDMAN SACHS GROUP INC
GS		 9,164
0.000%		 -3,964,486decrease
(-99.77%)		 Filing
2022-02-07
1:57 pm
Purchase		 2021-12-31 13G ProQR Therapeutics N.V.
PRQR		 GOLDMAN SACHS GROUP INC
GS		 3,973,650
5.600%		 467,286increase
(+13.33%)		 Filing